{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T10:45:21Z","timestamp":1788432321381,"version":"build-2803163510"},"reference-count":128,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2012,8,22]],"date-time":"2012-08-22T00:00:00Z","timestamp":1345593600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Dermatology"],"published-print":{"date-parts":[[2012,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:bold>Background\u2002<\/jats:bold> Cutaneous T\u2010cell lymphoma (CTCL) is a myeloproliferative disease with pronounced epidermotropism. The major subtypes of CTCL are mycosis fungoides and S\u00e9zary syndrome. Survival is dependent on the histological subtype and clinical stage. Early CTCL has a normal life expectancy, therefore early disease recognition and stage adapted treatment might help to ensure a good prognosis.<\/jats:p><jats:p><jats:bold>Methods\u2002<\/jats:bold> This is a review of recent advances in CTCL treatment based on literature review.<\/jats:p><jats:p><jats:bold>Results\u2002<\/jats:bold> Skin targeted therapies are useful for patch and limited plaque disease with phototherapy as the cornerstone of such treatments. More advanced disease will benefit from systemic mono\u2010 or combined treatments including drug therapy, extracorporeal photopheresis, and radiotherapy. In practice combined treatments may reduce adverse events and improve response rates. For selected younger patients, stem cell transplantation seems a third\u2010line option.<\/jats:p><jats:p><jats:bold>Conclusions\u2002<\/jats:bold> The therapeutic spectrum for CTCL has been advanced during the last years, providing the opportunity of tailored treatment for patients.<\/jats:p>","DOI":"10.1111\/j.1365-4632.2011.05337.x","type":"journal-article","created":{"date-parts":[[2012,8,22]],"date-time":"2012-08-22T06:47:53Z","timestamp":1345618073000},"page":"1019-1036","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Cutaneous T\u2003cell lymphoma: update on treatment"],"prefix":"10.1111","volume":"51","author":[{"given":"Uwe","family":"Wollina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,8,22]]},"reference":[{"key":"e_1_2_10_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra032810"},{"key":"e_1_2_10_3_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-09-3502"},{"key":"e_1_2_10_4_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.141.3.325"},{"key":"e_1_2_10_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22252"},{"key":"e_1_2_10_6_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.143.7.854"},{"key":"e_1_2_10_7_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-10-184168"},{"key":"e_1_2_10_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1610-0387.2007.06337.x"},{"key":"e_1_2_10_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2010.04567.x"},{"key":"e_1_2_10_10_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-05-154609"},{"key":"e_1_2_10_11_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2007-03-055749"},{"key":"e_1_2_10_12_2","first-page":"491","article-title":"Diagnosis and management of mycosis fungoides","volume":"24","author":"Galper SL","year":"2010","journal-title":"Oncology (Williston Park)"},{"key":"e_1_2_10_13_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.27.7665"},{"key":"e_1_2_10_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2009.01.044"},{"key":"e_1_2_10_15_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2005.07.033"},{"key":"e_1_2_10_16_2","doi-asserted-by":"publisher","DOI":"10.1593\/neo.06805"},{"key":"e_1_2_10_17_2","first-page":"157","article-title":"Confirmation of the biological significance of transthyretin as a biomarker for cutaneous T\u2003cell lymphoma by its protein interaction partners","volume":"4","author":"Escher N","year":"2011","journal-title":"Mol Med Report"},{"key":"e_1_2_10_18_2","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1001\/archderm.1994.01690020064010","article-title":"Profound deficiency in normal circulating T\u2003cells in erythrodermic cutaneous T\u2003cell lymphoma","volume":"130","author":"Heald P","year":"1994","journal-title":"Arch Dermatol"},{"key":"e_1_2_10_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.08.037"},{"key":"e_1_2_10_20_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.143.1.45"},{"key":"e_1_2_10_21_2","doi-asserted-by":"crossref","first-page":"21","DOI":"10.5070\/D34J11Z5Z7","article-title":"Fatal outcome due to bacterial superinfection of eczema herpeticum in a patient with mycosis fungoides","volume":"14","author":"Mallo\u2010Garc\u00eda S","year":"2008","journal-title":"Dermatol Online J"},{"key":"e_1_2_10_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexmp.2010.05.001"},{"key":"e_1_2_10_23_2","doi-asserted-by":"publisher","DOI":"10.2165\/11532190-000000000-00000"},{"key":"e_1_2_10_24_2","doi-asserted-by":"publisher","DOI":"10.1159\/000241302"},{"key":"e_1_2_10_25_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.134.8.949"},{"key":"e_1_2_10_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(89)70051-7"},{"key":"e_1_2_10_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/0190-9622(90)70112-U"},{"key":"e_1_2_10_28_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.138.3.325"},{"key":"e_1_2_10_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(84)70030-2"},{"key":"e_1_2_10_30_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.141.3.305"},{"key":"e_1_2_10_31_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.1992.01680170063007"},{"key":"e_1_2_10_32_2","first-page":"800","article-title":"The role of maintenance phototherapy in cutaneous T\u2003cell lymphoma","volume":"9","author":"Pothiawala SZ","year":"2010","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_10_33_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2010.04833.x"},{"key":"e_1_2_10_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-3083.2009.03500.x"},{"key":"e_1_2_10_35_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.det.2010.03.010"},{"key":"e_1_2_10_36_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2010.09793.x"},{"key":"e_1_2_10_37_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0151-9638(07)91813-X"},{"key":"e_1_2_10_38_2","doi-asserted-by":"publisher","DOI":"10.1089\/pho.2008.2317"},{"key":"e_1_2_10_39_2","first-page":"75","article-title":"Unilesional mycosis fungoides treated with photodynamic therapy. A case report","volume":"17","author":"Hegyi J","year":"2008","journal-title":"Acta Dermatovenereol Alp Panonica Adriat"},{"key":"e_1_2_10_40_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2010.02.039"},{"key":"e_1_2_10_41_2","doi-asserted-by":"publisher","DOI":"10.1155\/2010\/896161"},{"key":"e_1_2_10_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2003.08.007"},{"key":"e_1_2_10_43_2","first-page":"308","article-title":"Palliative total skin electron beam therapy (TSEBT) for advanced cutaneous T\u2003cell lymphoma","volume":"18","author":"Funk A","year":"2008","journal-title":"Eur J Dermatol"},{"key":"e_1_2_10_44_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1468-3083.2001.00348.x"},{"key":"e_1_2_10_45_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8588(18)30060-1"},{"key":"e_1_2_10_46_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.1.257"},{"key":"e_1_2_10_47_2","first-page":"3578","article-title":"Prospective randomized multicenter clinical trial on the use of interferon\u20102a plus acitretin versus interferon\u20102a plus PUVA in patients with cutaneous T\u2003cell lymphoma stages I and II","volume":"92","author":"Stadler R","year":"1998","journal-title":"Blood"},{"key":"e_1_2_10_48_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1529-8019.2006.00083.x"},{"key":"e_1_2_10_49_2","first-page":"581","article-title":"Phase II and III clinical trial of oral bexarotene (Targretin capsules) for the treatment of refractory or persistent early\u2010stage cutaneous T\u2003cell lymphoma","volume":"137","author":"Duvic M","year":"2001","journal-title":"Arch Dermatol"},{"key":"e_1_2_10_50_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.9.2456"},{"key":"e_1_2_10_51_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2003.11.058"},{"key":"e_1_2_10_52_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00280-010-1553-0"},{"key":"e_1_2_10_53_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22596"},{"key":"e_1_2_10_54_2","doi-asserted-by":"publisher","DOI":"10.3109\/09546630903103980"},{"key":"e_1_2_10_55_2","first-page":"33","article-title":"Bexarotene plus PUVA plus radiation combination therapy for mycosis fungoides","volume":"1","author":"Coors E","year":"2008","journal-title":"Dermatol Clin"},{"key":"e_1_2_10_56_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2007.07901.x"},{"key":"e_1_2_10_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2006.01.025"},{"key":"e_1_2_10_58_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2000.18.13.2615"},{"key":"e_1_2_10_59_2","first-page":"926","article-title":"Value of gemcitabine treatment in heavily pretreated Hodgkin\u2019s disease patients","volume":"85","author":"Zinzani PL","year":"2000","journal-title":"Haematologica"},{"key":"e_1_2_10_60_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21449"},{"key":"e_1_2_10_61_2","doi-asserted-by":"publisher","DOI":"10.3816\/CLM.2009.n.079"},{"key":"e_1_2_10_62_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-4632.2008.03993.x"},{"key":"e_1_2_10_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(00)90007-0"},{"key":"e_1_2_10_64_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-001-0304-3"},{"key":"e_1_2_10_65_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.11593"},{"key":"e_1_2_10_66_2","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.10879"},{"key":"e_1_2_10_67_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.144.6.727"},{"key":"e_1_2_10_68_2","doi-asserted-by":"crossref","unstructured":"DummerR WhittakerS HasanB et\u00a0al.EORTC 210.12 Phase II multicentre study of Caelyx\u2122 monotherapy in patients with advanced mycosis fungoides stage IIb IVa and IVb with or without previous chemotherapy. 52nd Annual Meeting and Exposition of the American Society of Hematology Orlando FL. Poster 2823.http:\/\/ash.cortex.com\/ash\/2010\/webprogram\/Paper32603.html. [Accessed April 25 2011.]","DOI":"10.1182\/blood.V116.21.2823.2823"},{"key":"e_1_2_10_69_2","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00432-002-0403-9","article-title":"Liposomal daunorubicin in tumor stage cutaneous T\u2003cell lymphoma: report of three cases","volume":"129","author":"Wollina U","year":"2003","journal-title":"J Cancer Res Clin Oncol"},{"key":"e_1_2_10_70_2","first-page":"337","article-title":"Extracorporeal photopheresis: a review on the immunological aspects and clinical applications","volume":"29","author":"Chiesa\u2010Fuxench ZC","year":"2010","journal-title":"P R Health Sci J"},{"key":"e_1_2_10_71_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2009-11-256040"},{"key":"e_1_2_10_72_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198702053160603"},{"key":"e_1_2_10_73_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1396-0296.2003.01646.x"},{"key":"e_1_2_10_74_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2000.105510"},{"key":"e_1_2_10_75_2","doi-asserted-by":"publisher","DOI":"10.1001\/archderm.138.8.1054"},{"key":"e_1_2_10_76_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0781.2007.00300.x"},{"key":"e_1_2_10_77_2","first-page":"479","article-title":"Extracorporeal photochemotherapy in cutaneous T\u2003cell lymphoma. An overview of current status","volume":"13","author":"Wollina U","year":"2006","journal-title":"Int J Immunopathol Pharmacol (Section Dermatol)"},{"key":"e_1_2_10_78_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.2001.tb03728.x"},{"key":"e_1_2_10_79_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2001.110645"},{"key":"e_1_2_10_80_2","first-page":"655","article-title":"Skin\u2010directed therapy for mycosis fungoides: a review","volume":"7","author":"Berthelot C","year":"2008","journal-title":"J Drugs Dermatol"},{"key":"e_1_2_10_81_2","first-page":"148","article-title":"Imiquimod in mycosis fungoides","volume":"18","author":"Mart\u00ednez\u2010Gonz\u00e1lez MC","year":"2008","journal-title":"Eur J Dermatol"},{"key":"e_1_2_10_82_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001813-200302000-00011"},{"key":"e_1_2_10_83_2","first-page":"115","article-title":"A Phase II trial of miltefosine in patients with cutaneous T\u2003cell lymphoma","volume":"93","author":"Dumontet C","year":"2006","journal-title":"Bull Cancer"},{"key":"e_1_2_10_84_2","doi-asserted-by":"publisher","DOI":"10.2217\/fon.10.83"},{"key":"e_1_2_10_85_2","first-page":"508","article-title":"Pralatrexate, a dihydrofolate reductase inhibitor for the potential treatment of several malignancies","volume":"11","author":"Molina JR","year":"2008","journal-title":"IDrugs"},{"key":"e_1_2_10_86_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-11-0556"},{"key":"e_1_2_10_87_2","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2011.572265"},{"key":"e_1_2_10_88_2","doi-asserted-by":"publisher","DOI":"10.1385\/MO:19:2S:S27"},{"key":"e_1_2_10_89_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-12-062877"},{"key":"e_1_2_10_90_2","first-page":"600","article-title":"Histone deacetylase inhibitors: potential in cancer therapy","volume":"107","author":"Marks PA","year":"2009","journal-title":"J Cell Biol"},{"key":"e_1_2_10_91_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.2010.01188.x"},{"key":"e_1_2_10_92_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0913912107"},{"key":"e_1_2_10_93_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0609.2005.00470.x"},{"key":"e_1_2_10_94_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.exphem.2004.09.008"},{"key":"e_1_2_10_95_2","first-page":"3578","article-title":"Phase I clinical trial of histone deacetylase inhibitor: suberoylanilide hydroxamic acid administered intravenously","volume":"9","author":"Kelly WK","year":"2003","journal-title":"Clin Cancer Res"},{"key":"e_1_2_10_96_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.14.167"},{"key":"e_1_2_10_97_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-06-025999"},{"key":"e_1_2_10_98_2","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp090247"},{"key":"e_1_2_10_99_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-2672"},{"key":"e_1_2_10_100_2","first-page":"718","article-title":"Phase I trial of the histone deacetylase inhibitor, depsipeptide (FR901228, NSC 630176), in patients with refractory neoplasms","volume":"8","author":"Sandor V","year":"2002","journal-title":"Clin Cancer Res"},{"key":"e_1_2_10_101_2","first-page":"1","article-title":"Romidepsin: evidence for its potential use to manage previously treated cutaneous T\u2003cell lymphoma","volume":"6","author":"Poligone B","year":"2011","journal-title":"Core Evid"},{"key":"e_1_2_10_102_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.28.9066"},{"key":"e_1_2_10_103_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.21.6150"},{"key":"e_1_2_10_104_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-4262"},{"key":"e_1_2_10_105_2","article-title":"A Phase I study of oral panobinostat (LBH589) in Japanese patients with advanced solid tumors","author":"Fukutomi A","year":"2011","journal-title":"Invest New Drugs"},{"key":"e_1_2_10_106_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2009.12.052"},{"key":"e_1_2_10_107_2","doi-asserted-by":"crossref","first-page":"11885","DOI":"10.1016\/S0021-9258(19)38482-0","article-title":"Structure\/function analysis of interleukin\u20102\u2010toxin (DAB 486\u2010IL\u20102). Fragment B sequences required for the delivery of fragment A to the cytosol of target cells","volume":"265","author":"Williams DP","year":"1990","journal-title":"J Biol Chem"},{"key":"e_1_2_10_108_2","first-page":"399","article-title":"Phase I trial of a ligand fusion\u2010protein (DAB 389 IL\u20102) in lymphomas expressing the receptor for interleukin\u20102","volume":"91","author":"LeMaistre CF","year":"1998","journal-title":"Blood"},{"key":"e_1_2_10_109_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2001.19.2.376"},{"key":"e_1_2_10_110_2","doi-asserted-by":"publisher","DOI":"10.1067\/mjd.2000.106373"},{"key":"e_1_2_10_111_2","doi-asserted-by":"publisher","DOI":"10.3816\/CLM.2000.s.010"},{"key":"e_1_2_10_112_2","doi-asserted-by":"publisher","DOI":"10.3816\/CLM.2001.n.005"},{"key":"e_1_2_10_113_2","doi-asserted-by":"publisher","DOI":"10.2165\/00063030-200923010-00001"},{"key":"e_1_2_10_114_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.26.2386"},{"key":"e_1_2_10_115_2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2147\/CMAR.S5009","article-title":"Role of denileukin diftitox in the treatment of persistent or recurrent cutaneous T\u2003cell lymphoma","volume":"2","author":"Lansigan F","year":"2010","journal-title":"Cancer Manag Res"},{"key":"e_1_2_10_116_2","doi-asserted-by":"publisher","DOI":"10.1001\/archdermatol.2010.147"},{"key":"e_1_2_10_117_2","doi-asserted-by":"publisher","DOI":"10.1099\/0022-1317-81-10-2341"},{"key":"e_1_2_10_118_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2004.04.029"},{"key":"e_1_2_10_119_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.67.10.6025-6032.1993"},{"key":"e_1_2_10_120_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.jid.5700529"},{"key":"e_1_2_10_121_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdermsci.2011.02.001"},{"key":"e_1_2_10_122_2","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-01-0360"},{"key":"e_1_2_10_123_2","doi-asserted-by":"publisher","DOI":"10.1038\/mt.2010.52"},{"key":"e_1_2_10_124_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.29.3241"},{"key":"e_1_2_10_125_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0889-8588(03)00114-X"},{"key":"e_1_2_10_126_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2007.12.021"},{"key":"e_1_2_10_127_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.25.8301"},{"key":"e_1_2_10_128_2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5070\/D315D591GP","article-title":"Efficacy of treatments for mycosis fungoides and S\u00e9zary syndrome: nationwide survey responses","volume":"11","author":"Gettler SL","year":"2005","journal-title":"Dermatol Online J"},{"key":"e_1_2_10_129_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1610-0387.2008.06710.x"}],"container-title":["International Journal of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1365-4632.2011.05337.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1365-4632.2011.05337.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T19:11:00Z","timestamp":1695496260000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1365-4632.2011.05337.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,22]]},"references-count":128,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["10.1111\/j.1365-4632.2011.05337.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1365-4632.2011.05337.x","archive":["Portico"],"relation":{},"ISSN":["0011-9059","1365-4632"],"issn-type":[{"value":"0011-9059","type":"print"},{"value":"1365-4632","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,22]]},"assertion":[{"value":"2012-08-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}